IMMUCELL CORP /DE/ Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Immucell Corp /De/ quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Immucell Corp /De/ Operating Income (Loss) for the quarter ending September 30, 2024 was -$575K, a 51.4% increase year-over-year.
  • Immucell Corp /De/ Operating Income (Loss) for the twelve months ending September 30, 2024 was -$3.27M, a 48.8% increase year-over-year.
  • Immucell Corp /De/ annual Operating Income (Loss) for 2023 was -$5.75M, a 150% decline from 2022.
  • Immucell Corp /De/ annual Operating Income (Loss) for 2022 was -$2.3M, a 993% decline from 2021.
  • Immucell Corp /De/ annual Operating Income (Loss) for 2021 was $257K.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$3.27M -$575K +$609K +51.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$3.87M -$1.39M -$82.1K -6.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$3.79M -$300K +$1.96M +86.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$5.75M -$1M +$630K +38.6% Oct 1, 2023 Dec 31, 2023 10-Q 2024-11-13
Q3 2023 -$6.38M -$1.18M -$567K -92% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$5.81M -$1.3M -$685K -111% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$5.13M -$2.26M -$2.83M -495% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$2.3M -$1.63M -$1.78M -1224% Oct 1, 2022 Dec 31, 2022 10-Q 2024-11-13
Q3 2022 -$520K -$617K -$888K -328% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $368K -$619K -$835K -387% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $1.2M $571K +$945K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $257K $145K +$780K Oct 1, 2021 Dec 31, 2021 10-Q 2023-11-13
Q3 2021 -$522K $271K +$523K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q2 2021 -$1.05M $216K +$907K Apr 1, 2021 Jun 30, 2021 10-Q/A 2022-11-21
Q1 2021 -$1.95M -$375K -$572K -290% Jan 1, 2021 Mar 31, 2021 10-Q/A 2022-11-21
Q4 2020 -$1.38M -$634K -$392K -162% Oct 1, 2020 Dec 31, 2020 10-Q 2022-11-21
Q3 2020 -$988K -$252K +$178K +41.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$1.17M -$691K -$144K -26.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$1.02M $197K -$68.4K -25.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$954K -$242K +$683K +73.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 -$1.64M -$430K -$281K -188% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$1.36M -$547K -$354K -183% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$1M $265K +$443K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$1.45M -$926K -$513K -124% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 -$934K -$149K +$333K +69.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$1.27M -$193K +$71.9K +27.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 -$1.34M -$178K -$1.1M -119% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 -$243K -$413K -$533K -446% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-22
Q3 2017 $290K -$482K -$533K -1056% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $823K -$265K -$287K -1336% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 $1.11M $918K +$219K +31.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 $890K $119K -$342K -74.1% Oct 1, 2016 Dec 31, 2016 10-K 2017-03-30
Q3 2016 $1.23M $50.5K -$576K -91.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 $1.81M $21.5K -$193K -90% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $2M $699K -$121K -14.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 $2.12M $461K +$263K +132% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 $1.86M $627K +$586K +1434% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-30
Q2 2015 $1.27M $214K +$673K Apr 1, 2015 Jun 30, 2015 10-K 2017-03-30
Q1 2015 $601K $820K +$807K +6429% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-30
Q4 2014 -$206K $199K +$409K Oct 1, 2014 Dec 31, 2014 10-K 2016-03-25
Q3 2014 -$615K $40.9K +$201K Jul 1, 2014 Sep 30, 2014 10-K 2016-03-25
Q2 2014 -$816K -$459K -$482K -2034% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-25
Q1 2014 -$334K $12.6K -$314K -96.2% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-25
Q4 2013 -$19.6K -$210K -$222K -1780% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-25
Q3 2013 $203K -$160K -$73.8K -85.7% Jul 1, 2013 Sep 30, 2013 10-K 2016-03-25
Q2 2013 $277K $23.7K -$13.7K -36.6% Apr 1, 2013 Jun 30, 2013 10-K 2016-03-25
Q1 2013 $290K $327K +$45.4K +16.2% Jan 1, 2013 Mar 31, 2013 10-K 2016-03-25
Q4 2012 $245K $12.5K +$3.12K +33.2% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-26
Q3 2012 $242K -$86.1K +$106K +55.2% Jul 1, 2012 Sep 30, 2012 10-K 2015-03-26
Q2 2012 $136K $37.4K +$470K Apr 1, 2012 Jun 30, 2012 10-K 2015-03-26
Q1 2012 -$335K $281K +$298K Jan 1, 2012 Mar 31, 2012 10-K 2015-03-26
Q4 2011 -$633K $9.38K Oct 1, 2011 Dec 31, 2011 10-K 2014-03-26
Q3 2011 -$192K +$155K +44.6% Jul 1, 2011 Sep 30, 2011 10-K 2014-03-26
Q2 2011 -$433K -$480K -1009% Apr 1, 2011 Jun 30, 2011 10-K 2014-03-26
Q1 2011 -$16.9K Jan 1, 2011 Mar 31, 2011 10-K 2014-03-26
Q3 2010 -$348K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 $47.6K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.